Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma 54Dendritic Cell Sarcoma, Interdigitating 38Lymphoma 37Burkitt Lymphoma 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Large B-Cell, Diffuse 27Leukemia 27Lymphoma, Non-Hodgkin 25Recurrence 24Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Follicular 23Lymphoma, Mantle-Cell 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Acute 21Neuroectodermal Tumors, Primitive, Peripheral 19Hodgkin Disease 19Osteosarcoma 18Multiple Myeloma 18Myeloproliferative Disorders 17Central Nervous System Neoplasms 17Astrocytoma 17Neoplasms, Plasma Cell 16Leukemia, Myeloid, Chronic-Phase 16Rhabdomyosarcoma 15Leukemia, Myeloid, Accelerated Phase 15Blast Crisis 15Ovarian Neoplasms 14Neuroblastoma 13

Interventions

pevonedistat 1Vincristine 1Rituximab 1Prednisone 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acromesomelic dysplasia, Maroteaux type × Filgrastim × Sarcoma × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡